UP Philippine General Hospital Division of Endocrinology, diabetes & metabolism consensus recommendations for in-patient management of diabetes mellitus among persons with COVID-19 / Cecilia Jimeno [and seven others]

Contributor(s): Subject(s):
Online resources:
Abstract: Diabetes mellitus (DM) is a known risk factor for morbidity and mortality among patients with COVID-19 based on recent studies. While there are many local and international guidelines on inpatient management of diabetes, the complicated pathology of the virus, the use of glucose-elevating drugs such as glucocorticoids, antivirals and even inotropes, and various other unique problems has made the management of in-hospital hyperglycemia among patients with COVID-19 much more difficult than in other infections. The objective of this guidance is to collate and integrate the best available evidence that has been published regarding in-patient management of diabetes among patients with COVID-19. A comprehensive review of literature was done and recommendations have been made through a consensus of expert endocrinologists from the University of the Philippines-Philippine General Hospital (UP-PGH) Division of Endocrinology, Diabetes and Metabolism. These recommendations are evolving as we continue to understand the pathology of the disease and how persons with diabetes are affected by this virus.
Hello from Record Display Customizations!
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Cover image Item type Current library Home library Collection Shelving location Call number Materials specified Vol info URL Copy number Status Notes Date due Barcode Item holds Item hold queue priority Course reserves
COVID 19 Resource DOH Central Library Electronic Resource Section COVID-19-000087 (Browse shelf) Available D0001C000087

Diabetes mellitus (DM) is a known risk factor for morbidity and mortality among patients with COVID-19 based on recent
studies. While there are many local and international guidelines on inpatient management of diabetes, the complicated
pathology of the virus, the use of glucose-elevating drugs such as glucocorticoids, antivirals and even inotropes, and
various other unique problems has made the management of in-hospital hyperglycemia among patients with COVID-19
much more difficult than in other infections. The objective of this guidance is to collate and integrate the best available
evidence that has been published regarding in-patient management of diabetes among patients with COVID-19.
A comprehensive review of literature was done and recommendations have been made through a consensus of expert
endocrinologists from the University of the Philippines-Philippine General Hospital (UP-PGH) Division of Endocrinology,
Diabetes and Metabolism. These recommendations are evolving as we continue to understand the pathology of the
disease and how persons with diabetes are affected by this virus.

In: JAFES 2020; vol. 35 (1) pages: 14-25

There are no comments on this title.

to post a comment.